Harvard Rest Haven in Harvard, NE

Harvard Rest Haven is a medicare and medicaid certified nursing home in Harvard, Nebraska. It is located in Clay county at 400 East 7th Street, Harvard, Nebraska 68944. You can reach out to the office of Harvard Rest Haven via phone at (402) 772-7591. This skilled nursing facility has 37 federally certified beds with average occupancy rate of 39.46%. Its legal business name is City Of Harvard and has the following ownership type - For Profit - Corporation.

Harvard Rest Haven (Medicare CCN 285272) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2006 (18 years certified) and the last quality survey was conducted in October, 2019.

Name	Harvard Rest Haven
Location	400 East 7th Street, Harvard, Nebraska
Certified By	Medicare and Medicaid
No. of Certified Beds	37
Occupancy Rate	39.46%
Medicare ID (CCN)	285272
Legal Business Name	City Of Harvard
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Harvard Rest Haven from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Harvard Rest Haven are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Harvard Rest Haven give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Hana Biosciences reports complete data from Marqibo Phase 2 RALLY trial for relapsed/refractory adult ALL

Hana Biosciences Inc.,, today announced complete data from its pivotal, Phase 2 RALLY clinical trial for Marqibo® (vincristine sulfate liposome injection) for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). Results from the RALLY trial demonstrated compelling evidence of single-agent, anti-leukemic activity in an advanced, heavily pre-treated, adult ALL population.

XTL Biopharmaceuticals purchases 4,620,356 shares of Proteologics from Teva

XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).

Gut's immune response to SARS-CoV-2 very different from the lung

Megan L. Stanifer et al. study the immune response in the human gut upon SARS-CoV-2 infection. The study published as a bioRxiv* preprint reveals a robust proinflammatory response: a cell type-specific or a tissue-specific regulation of interferon-mediated signaling during SARS-CoV-2 infection.

AMCC to raise awareness about dangers of prescription drug abuse across the U.S.

On November 12, 2016 the 7th Annual American Medicine Chest Challenge -- a national public health initiative to raise awareness about the dangers of prescription drug abuse and encourage safe disposal of prescription drugs will be held in communities throughout the nation.

Cuisinart launches the CleanWater Countertop Filtration System to reduce dependency on plastic water bottles

The Container Recycling Institute reports that Americans will buy an estimated 34.6 billion single-serve (1 liter or less) plastic water bottles in 2009. More than 75 percent of those bottles will end up in landfills or incinerators, rather than being recycled. That's 877 bottles wasted every second, according to the Institute.

Read more Medical News

› Verified 5 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Harvard Rest Haven is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	14.81	14.46
Percentage of long-stay residents who lose too much weight	5.19	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	50	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	6.85	1.79
Percentage of long-stay residents with a urinary tract infection	7.14	2.65
Percentage of long-stay residents who have depressive symptoms	0	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	0.98	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	96.08	93.87
Percentage of long-stay residents who received an antipsychotic medication	15.22	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	81.48	83.88